Trending...
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media
SEMINOLE, Fla. & KARLSRUHE, Germany - Californer -- MIRAmedtech UG and Bio-Infusions USA announced today that they a have entered into an agreement, effective immediately, to provide a complete line of comprehensive aesthetic medical devices and topical treatments to cosmetic dermatologists, plastic surgeons, and aesthetic practitioners for the benefit of their patients throughout the United States.
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on The Californer
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on The Californer
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on The Californer
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Author Explodes Damning Myths about Hunger in America
- California: Happy Birthday, National Guard!
- Umbrella by J French Premieres Live at 8586 in the Beverly Center on December 22
- Affordable Luxury Bracelets to Gift This Christmas: Timeless Style with 40% Holiday Savings
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on The Californer
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- The Iconic Cops TV Show Is Now Streaming on AwepraTV
- Matt Ox Releases New Visual Content Highlighting Artistic Growth and Collaboration
- Silva Construction Unveils 2026 Design Trends
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
Source: Bio-Infusions USA
0 Comments
Latest on The Californer
- Governor Newsom deploys California resources to Washington to support flood response efforts
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Relief Alliance Skid Row Outreach Brings Celebrities and Volunteers Together for Community Impact
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Car Wash in Northridge Under $10
- Only 3 Spots Left for Rise Within: Wellness Retreat Los Cabos – January 2026
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- bisco industries New Authorized Line: SKF Aerospace
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Baby Boomers: The Perfect Cash Buyers in Today's Market
- Stray Theories Unveils Falter, an Atmospheric Passage Through the Spaces Between Doubt and Hope
- Holiday Decorations Most Likely to Cause Injuries
- Daniel S. Romero, CFP® Earns Renowned Certification for Fiduciary Excellence
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- California: Coho salmon are making a comeback in the Russian River for the first time in 30 years
- DKN Hotels Acquires Residence Inn by Marriott San Diego Sorrento Mesa/Sorrento Valley
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI